Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
24,039,860
-
Share change
-
+416,964
-
Total reported value
-
$2,488,843,397
-
Put/Call ratio
-
86%
-
Price per share
-
$103.53
-
Number of holders
-
113
-
Value change
-
+$43,662,335
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2013
As of 31 Dec 2013,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,039,860 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, LORD, ABBETT & CO. LLC, VANGUARD GROUP INC, Citadel Advisors LLC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, State Street Corp, and FEDERATED INVESTORS INC /PA/.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.